🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will investigate the safety and efficacy of TIL therapy in patie...
Status
Completed
Location
Yale School of Medicine
Start Date
2019-12-23
Trial ID
NCT04111510
Treatments Being Tested
Phase 1b open-label study to evaluate the safety of selected TIL (TBio-4101...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2024-03-14
Trial ID
NCT06236425
Treatments Being Tested
Background: The presence of T-lymphocytes in resected tumor samples derive...
Status
Recruiting
Location
Vall d'Hebron Institute of Oncology
Start Date
2025-01-15
Trial ID
NCT06630611
Background: The presence of T-lymphocytes in resected tumor samples derive...
Status
Recruiting
Location
Vall d'Hebron Institute of Oncology
Start Date
2021-10-28
Trial ID
NCT05141474
Treatments Being Tested
This is a Phase 2, multicenter, open-label study of lifileucel (tumor-infil...
Status
Active Not Recruiting
Location
Sarah Cannon Research Institute
Start Date
2025-11-28
Trial ID
NCT07288203
Treatments Being Tested
This is an open label study evaluating lifileucel (LN-144) in patients with...
Status
Recruiting
Location
Memorial Sloan Kettering Westchester
Start Date
2022-11-01
Trial ID
NCT05607095
Treatments Being Tested
A total of 92 subjects with advanced melanoma who met the inclusion criteri...
Status
Recruiting
Location
Beijing Go Broad Hospital
Start Date
2025-12-16
Trial ID
NCT07310784
Treatments Being Tested
A study of lifileucel (tumor-infiltrating lymphocytes) in adults with advan...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-01
Trial ID
NCT07741877
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of adjuvant adoptive ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-12-02
Trial ID
NCT06190249
Treatments Being Tested
A prospective, open-label, multi-cohort, non-randomized, multicenter Phase ...
Status
Terminated
Location
University of California, San Diego
Start Date
2019-05-07
Trial ID
NCT03645928